🇺🇸 FDA
Patent

US 6846799

Preventing airway mucus production by administration of EGF-R antagonists

expired A61KA61K2039/505A61K31/00

Quick answer

US patent 6846799 (Preventing airway mucus production by administration of EGF-R antagonists) held by The Regents of the University of California expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K31/00, A61P, A61P11/00